|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 133.17 EUR | 0.00% |
|
-2.58% | +20.55% |
| 08-03 | Correction to Novartis Wins FDA Approval for Expanded Prostate Cancer Treatment Article on July 31 | DJ |
| 08-03 | Is Everything Under Control? |  |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.64% | -8.26% | -6.69% | +15.69% | +4.20% | +45.62% | +149.13% | +326.64% | +1,258.66% | 1T | |
| -0.27% | -4.98% | -2.26% | +13.05% | +22.47% | +48.19% | +49.94% | +46.20% | +104.63% | 613B | |
| -0.56% | -7.42% | -4.36% | +17.05% | +6.64% | +23.56% | +64.93% | +111.73% | +268.62% | 433B | |
| +0.48% | -2.77% | +7.81% | +13.02% | +8.99% | +40.27% | +34.96% | +1.05% | +45.58% | 350B | |
| +2.09% | -9.27% | -16.74% | -11.93% | -14.87% | +5.42% | +7.61% | +41.96% | +127.83% | 239B | |
| +1.75% | -8.29% | -4.20% | +8.71% | -5.43% | -1.73% | -42.05% | +0.69% | +67.63% | 206B | |
| +2.09% | -1.60% | +5.56% | +19.44% | +18.18% | +28.11% | +59.00% | +69.42% | +124.01% | 204B | |
| -0.01% | -2.37% | +1.18% | -1.17% | +6.84% | +14.52% | +66.68% | +89.40% | +64.40% | 163B | |
| +1.74% | +0.89% | +7.40% | -3.14% | +2.31% | +8.27% | -27.26% | -43.63% | -27.52% | 143B | |
| +0.73% | +3.47% | +16.07% | +14.69% | +22.01% | +44.96% | +8.79% | -3.91% | -12.63% | 134B | |
| +1.40% | -2.54% | -9.75% | +11.19% | +5.42% | +1.20% | +40.37% | +139.46% | +376.60% | 119B | |
| +0.26% | -5.64% | -3.45% | +3.10% | +4.93% | +36.90% | +42.13% | +6.84% | -9.85% | 103B | |
| -0.15% | -6.29% | -0.16% | -4.40% | -10.07% | -9.28% | -20.79% | -11.96% | +2.25% | 103B | |
| -0.10% | -2.45% | -12.59% | -18.98% | -18.96% | -8.99% | +60.89% | +66.83% | +440.16% | 70.18B | |
| -2.26% | -8.37% | -1.36% | +0.90% | +9.33% | +25.35% | +21.16% | +44.74% | +11.94% | 55.08B | |
| +2.40% | +2.59% | -5.72% | +29.01% | +30.37% | +75.49% | -6.53% | -3.16% | -48.64% | 53.26B | |
| +0.79% | -0.34% | -1.89% | -0.85% | -10.32% | -12.87% | +26.38% | -6.93% | +228.63% | 51.77B | |
| -1.27% | -6.09% | -0.22% | +7.10% | -4.56% | +0.53% | +11.17% | - | - | 42.85B | |
| -0.49% | +8.46% | -2.66% | -2.83% | +10.06% | +118.93% | +251.95% | +243.50% | -38.05% | 40.16B | |
| Average | +0.46% | -1.83% | -1.79% | +5.77% | +4.61% | +25.50% | +42.02% | +62.16% | +165.79% | 217.02B | |
| Weighted average by Cap. | +0.24% | -3.52% | -2.57% | +10.06% | +6.80% | +30.95% | +62.46% | +114.80% | +395.36% |
- Stock Market
- Stocks
- NOVN Stock
- NOVN Stock
- Sector Novartis
Select your edition
All financial news and data tailored to specific country editions
